Bull Moose Tube to Acquire Hanna Steel in Third U.S. Manufacturing Expansion


Bull Moose Tube Company has agreed to acquire Hanna Steel, a producer of structural and mechanical steel tubing with facilities in Alabama and Illinois.

Most industrial buy-and-build strategies come with a clock. This one does not.

More than fifty years ago, Lord Swraj Paul founded a steel tube business in Britain called Natural Gas Tubes. That company eventually became Caparo Group, a global industrial enterprise spanning steel, automotive components, and engineered products. Today, the family he founded is once again expanding through steel tube manufacturing—this time in the United States.

The latest example is Bull Moose’s agreement to acquire Hanna Steel, a producer of structural and mechanical steel tubing. The transaction, expected to close in the third quarter of 2026, extends what has become a steady expansion strategy by the Paul family and its Caparo Group, one that has received little attention despite a growing series of investments in American manufacturing assets.

Founded in 1954, Hanna Steel manufactures structural and mechanical steel tubing used in commercial construction, infrastructure, and industrial applications. The company operates tubing facilities in Alabama and Illinois, a coil-coating operation in Alabama, and its own trucking business. Industry sources estimate annual revenue of approximately $80 million and employment of several hundred workers. Its Tuscaloosa facility alone spans more than 600,000 square feet.

Hanna Steel’s Tuscaloosa, Louisiana facility. Credit: Hanna Steel

The acquisition of Hanna Steel marks the end of more than 40 years of Hanna family ownership, dating to 1984 when Pete Hanna purchased the company from his father, General Hanna, and expanded it into one of the nation’s largest independent producers of structural and mechanical steel tubing.

“The acquisition of Hanna Steel is a strong strategic fit for Bull Moose as we continue to expand our capabilities and enhance value for our customers,” said John Krupinski, chief executive officer of Bull Moose Tube. “Hanna adds complementary assets, experienced teams, a respected reputation and culture, along with a product portfolio that supports our long-term growth strategy.”

Bull Moose Tube Company was founded in 1962 and is headquartered near St. Louis in Chesterfield, Missouri. Today, the company operates seven manufacturing facilities across the United States and is one of North America’s larger producers of welded steel tubing, hollow structural sections, and mechanical tubing. Under the ownership of the Paul family, Bull Moose has grown into a business with annual production capacity exceeding one million tons.

Bull Moose Tube’s Elkhart, Indiana facility: Credit Bull Moose Tube

Bull Moose is owned by Caparo Bull Moose, the North American subsidiary of Caparo Group. Following Lord Paul’s death in August 2025, leadership of the family-controlled business passed to his son, Ambar Paul, who serves as chairman of Bull Moose Tube.

“We continue to assess and pursue strategic opportunities that strengthen Bull Moose Tube’s position as a best-in-class steel tube producer,” said Mr. Paul. “As our third major investment in recent years, Hanna Steel builds on a clear pattern of strategic expansion, adding depth to our manufacturing capabilities and reinforcing our commitment to long-term, sustainable growth.”

The Hanna acquisition follows Bull Moose’s September 2025 purchase of Ferrous85 from privately held Ferragon Corporation. The Sinton, Texas-based toll-processing business operates adjacent to Steel Dynamics’ steel campus and includes one of North America’s largest steel coil slitting operations, capable of processing coils weighing up to 105,000 pounds. The acquisition strengthened Bull Moose’s Texas manufacturing platform, which the company began building in 2021 with plans for a new hollow structural section and sprinkler pipe mill in Sinton.

Hanna Steel’s Tuscaloosa, Louisiana facility. Credit: Hanna Steel

The company also closed its Burlington, Ontario, manufacturing facility in 2025, consolidating production into its U.S. operations. Taken together, these investments point toward a strategy focused on increasing domestic manufacturing capacity and deepening exposure to the American industrial economy.

The timing is notable. Domestic steel demand continues to benefit from infrastructure spending, utility grid modernization, energy projects, manufacturing reshoring, and data center construction. Bull Moose participates in many of those end markets through its tubing and structural products businesses.

The broader steel tubing market remains fragmented despite decades of consolidation. Participants range from publicly traded producers to privately held regional manufacturers, creating ongoing opportunities for strategic buyers seeking additional capacity, geographic reach, and product breadth. Against that backdrop, Hanna Steel represents another building block in Bull Moose’s expansion strategy.

For the Paul family, Hanna Steel is the latest step in a strategy that has included new manufacturing capacity in Texas, the acquisition of Ferrous85, and a growing concentration of operations in the United States.

While most industrial buy-and-build programs are associated with private equity sponsors, Bull Moose is pursuing a similar path under family ownership and without the constraints of a traditional fund life.

Free Training

Source link

FH Capital to Acquire 75.1 Percent Stake in JinkoSolar US Manufacturing Unit, Expand Solar and BESS Platform – Asia Pacific


FH Capital will acquire 75.1 percent of JinkoSolar’s US manufacturing subsidiary, expand 2 GW solar module capacity, and launch domestic BESS production to strengthen America’s clean energy manufacturing and supply chain.

May 13, 2026. By EI News Network

FH Capital has entered into an agreement to acquire a 75.1 percent majority stake in JinkoSolar’s US manufacturing subsidiary, creating a domestic solar and Battery Energy Storage Systems (BESS) platform anchored by a 2 GW solar module manufacturing facility in the United States. JinkoSolar will retain a 24.9 percent minority stake in the venture.

Following the transaction, FH Capital plans to inject additional expansion capital to at least double the facility’s current solar module production capacity while also launching domestic BESS manufacturing operations. The move is aimed at strengthening US-based clean energy manufacturing amid rising demand for locally sourced solar and storage products and evolving US energy policies.

FH Capital is led by Sanjeev Chaurasia, a renewable energy investment banker with more than two decades of experience. Chaurasia previously served as Managing Director at Credit Suisse, where he co-founded the firm’s renewable energy practice and led JinkoSolar’s 2010 NYSE IPO.

According to Chaurasia, the transaction combines JinkoSolar’s established US manufacturing presence, technology portfolio, and customer network with FH Capital’s investment and operational capabilities to support growing domestic solar and storage demand.

Nigel Cockroft, US General Manager of JinkoSolar, said that the partnership provides strategic direction and ownership support to expand manufacturing capacity and serve increasing demand for US-sourced renewable energy products.

The transaction remains subject to customary regulatory approvals and closing conditions. Financial details of the deal were not disclosed.

Free Training

Source link

FH Capital To Acquire Majority Stake In JinkoSolar’s U.S. Manufacturing Operations


FH Capital announced that it has entered into a definitive agreement to acquire a 75.1% majority stake in Jinko Solar (U.S.) Industries, the U.S. manufacturing subsidiary of JinkoSolar.

Under the agreement, JinkoSolar will retain a 24.9% minority interest in the business. Financial terms of the transaction were not disclosed.

The transaction transfers controlling ownership of JinkoSolar’s U.S.-based 2 gigawatt solar module manufacturing facility along with its growing Battery Energy Storage Systems business.

Following the closing, FH Capital said it plans to invest additional expansion capital to at least double the current solar module manufacturing capacity while also launching domestic BESS manufacturing operations.

According to the companies, the combined platform is intended to address growing U.S. demand for domestically manufactured solar and energy storage products amid evolving clean energy policy initiatives and infrastructure investment trends.

FH Capital is led by Managing Partner Sanjeev Chaurasia, a renewable energy investment banker and investor with more than two decades of industry experience. Chaurasia previously served as Managing Director at Credit Suisse, where he co-founded the firm’s renewable energy practice and led JinkoSolar’s 2010 IPO on the New York Stock Exchange.

JinkoSolar has operated manufacturing operations in the United States for seven years and maintains a global production and sales footprint spanning multiple international markets.

The transaction remains subject to customary closing conditions and regulatory approvals.

Latham & Watkins served as legal counsel to FH Capital. Morgan Stanley Asia acted as financial advisor to JinkoSolar, while Cleary Gottlieb Steen & Hamilton served as legal counsel.

KEY QUOTES:

“The transaction leverages JinkoSolar’s well established seven-year U.S. manufacturing presence, proven technology, and strong relationships with blue-chip U.S. customers, with FH Capital’s capabilities to create and manage a dynamic platform positioned to meet rising demand for domestic solar and storage solutions.”

Sanjeev Chaurasia, Managing Partner, FH Capital

“FH Capital brings deep sector expertise, financing experience, and a deep understanding of the U.S. market.”

“We believe this transaction provides the right ownership, management and strategic direction for this new venture to grow capacity and serve the growing demand for high performance U.S.-sourced renewable energy products.”

Nigel Cockroft, U.S. General Manager, JinkoSolar

 

Free Training

Source link

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States


  • Milestone marks progress against AbbVie‘s previously announced commitment to invest more than $10 billion of capital in the U.S. over the next decade to broadly support innovation and expand critical manufacturing capabilities and capacity
  • Supports production of AbbVie‘s current and next-generation immunology and neuroscience medicines
  • Transaction anticipated to close in mid-2026

AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West. The acquisition of the manufacturing site will significantly expand AbbVie‘s drug delivery device manufacturing capabilities and capacity.

AbbVie plans to hire approximately 200 employees at the site and invest more than $175 million to acquire, as well as modernize and fully integrate it into its global manufacturing network. The combination of this acquisition and associated planned investments are part of AbbVie‘s commitment to expanding its pharmaceutical manufacturing in the United States (U.S.), supporting innovation and improving patient access and outcomes.

“Over the next decade, AbbVie is investing more than $10 billion in capital to broadly support innovation and expand our manufacturing capabilities and capacity in the U.S.,” said Robert A. Michael, chairman and chief executive officer, AbbVie. “With this investment, AbbVie is strengthening our manufacturing capabilities, ensuring we are well-positioned to develop and deliver next-generation medicines that make a remarkable impact on patients’ lives.”

The transaction includes the transfer of manufacturing facilities, including multiple production lines, and 3.5 mL on-body injector technology to support production of current and next-generation AbbVie immunology and neuroscience medicines.

With a presence in all 50 states and Puerto Rico, AbbVie employs approximately 29,000 people in the U.S., including more than 6,000 at its 11 U.S. manufacturing sites. When completed, this acquisition will significantly expand AbbVie‘s presence and economic impact in Arizona.

The transaction is anticipated to close in mid-2026, subject to closing conditions.

About AbbVie 

AbbVie‘s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn, FacebookInstagramX (formerly Twitter) and YouTube. 

Forward-Looking Statements  

Some statements in this news release are, or may be considered, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “anticipate,” “project” and similar expressions and uses of future or conditional verbs, generally identify forward-looking statements. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. Such risks and uncertainties include, but are not limited to, challenges to intellectual property, competition from other products, difficulties inherent in the research and development process, adverse litigation or government action, changes to laws and regulations applicable to our industry, the impact of global macroeconomic factors, such as economic downturns or uncertainty, international conflict, trade disputes and tariffs, and other uncertainties and risks associated with global business operations. Additional information about the economic, competitive, governmental, technological and other factors that may affect AbbVie‘s operations is set forth in Item 1A, “Risk Factors,” of AbbVie‘s 2024 Annual Report on Form 10-K, which has been filed with the Securities and Exchange Commission, as updated by its Quarterly Reports on Form 10-Q and in other documents that AbbVie subsequently files with the Securities and Exchange Commission that update, supplement or supersede such information. AbbVie undertakes no obligation, and specifically declines, to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. 

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-acquire-arizona-manufacturing-facility-further-strengthening-manufacturing-capabilities-in-the-united-states-302658118.html

SOURCE AbbVie



Free Training

Source link